FutureCeuticals Files Patent for Crucifeous Sprouts

FutureCeuticals, Momence, IL, has filed a patent that outlines claims regarding the ability of combinations of cruciferous sprouts and others to lower oxidized low-density lipoproteins (oxLDL) in human blood. After examining results from extensive screening for biological activity of different sprouts from the company’s SproutGarden line, scientists developed a blend that focuses on improving heart health by lowering oxLDL, which is widely recognized as a progenitor of heart disease and other vascular conditions.